C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/208, 167/244
C07D 311/68 (2006.01) C07D 311/58 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01)
Patent
CA 1308105
Abstract Compounds of formula (I) and pharmaceutically acceptable salts thereof: Image (I) wherein: Y is N or (when R3 is hydroxy, C1-6 alkoxy or C1-7 acyloxy) CH; one of R1 and R2 is hydrogen or C1-4 alkyl and the other is C1-4 alkyl or R1 and R2 together are C2-5- polymethylene; R3 is hydrogen, hydroxy, C1-6 alkoxy or C1-7 acyloxy; R4 is a C3-8 cycloalkyl group or a C1-6 alkyl group optionally substituted by a group R7 which is hydroxy, C1-6 alkoxy, amino optionally substituted by one or two C1-6 alkyl groups; C1-7 alkanoylamino, C3-8 cycloalkyloxy, C3-8 cycloalkylamino, or 1,3-dioxo-2- isoindoline; when Y is N, R5 is hydrogen, C1-6 alkyl optionally substituted by halogen, hydroxy, C1-6 alkoxy, C1-6 alkoxycarbonyl, carboxy or amino optionally substituted by one or two independent C1-6 alkyl groups, or C2-6 alkenyl, amino optionally substituted by a C1-6 alkyl, C3-8 cycloalkyl or C1-6 alkenyl group or by a C1-6 alkanoyl group optionally substituted by up to three halo atoms, by a phenyl group optionally substituted by C1-6 alkyl, C1-6 alkoxy or halogen, or aryl or heteroaryl, either being optionally substituted by one or more groups or atoms selected from the class of C1-6 alkyl, C1-6 alkoxy, hydroxy, halogen, trifluoromethyl, nitro, cyano, C1-12 carboxylic acyl, or amino or aminocarbonyl optionally substituted by one or two C1-6 alkyl groups and R6 is hydrogen or C1-6 alkyl, or R5 and R6 together are -CH2-(CH2)n-Z-(CH2)m- wherein m and n are 0 to 2 such that m + n is 1 or 2 and Z is CH2, O, S or NR wherein R is hydrogen, C1-9 alkyl, C2-7 alkanoyl, phenyl C1-4-alkyl, napthylcarbonyl, phenylcarbonyl or benzyl-carbonyl optionally substituted in the phenyl or naphthyl ring by one or two of C1-6 alkyl, C1-6 alkoxy or halogen; mono- or bi-cyclic- heteroarylcarbonyl; When Y is CH, R5 is NR8R9 wherein R8 and R9 are independently C1-6 alkyl, R8 is hydrogen and R9 is C1-6 alkyl or R8 and R9 together are C4-5 polymethylene; or R6 and R8 together are -(CH2)p- wherein p is 2 or 3, and R9 is hydrogen or C1-6 alkyl; or R5 is CH2R10 wherein R10 is hydrogen or C1-5 alkyl; or R6 and R10 are -(CH2)q- wherein q is 2 or 3; X is oxygen or sulphur; or R5, R6, X and Y (when N) together are tetrahydro- isoquinolinone or tetrahydroisoquinolinthione, optionally substituted in the phenyl ring as defined for R above; 3-3 the nitrogen-containing group in the 4-position being trans to the R3 group when R3 is hydroxy, C1-6 alkoxy or C1-7 acyloxy; having K+ channel activator activity, processes for their preparation and their use as pharmaceuticals.
536173
Burrell Gordon
Cassidy Frederick
Evans John M.
Stemp Geoffrey
Beecham Group P.l.c.
Borden Ladner Gervais Llp
Burrell Gordon
Cassidy Frederick
Evans John M.
LandOfFree
2h-1-benzapyran compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2h-1-benzapyran compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2h-1-benzapyran compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1218067